Inflammation biomarkers and risk of all-cause mortality in the reasons for geographic and racial differences in stroke cohort

American Journal of Epidemiology

Volumn 174, Issue 3, 2011, Pages 284-292

  Kabagambe, Edmond K ^a   Judd, Suzanne E ^a   Howard, Virginia J ^a   Zakai, Neil A ^b   Jenny, Nancy S ^b   Hsieh, Matthew ^c   Warnock, David G ^d   Cushman, Mary ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

biological markers; C reactive protein; cohort studies; inflammation; leukocytes; mortality; prospective studies

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN;

AGE CLASS; BIOMARKER; BLOOD; BODY SIZE; CARDIOVASCULAR SYSTEM; COHORT ANALYSIS; CONFIDENCE INTERVAL; CYTOLOGY; EDUCATIONAL ATTAINMENT; GEOGRAPHICAL VARIATION; HEALTH RISK; MEDICAL GEOGRAPHY; MORTALITY RISK; PREDICTION; PROTEIN; RACE; RISK ASSESSMENT; RISK FACTOR; SMOKING; SOCIOECONOMIC CONDITIONS; TEMPORAL ANALYSIS;

ADULT; AGE; ALBUMIN BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; DISEASE MARKER; FEMALE; HIGH RISK PATIENT; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; SEX DIFFERENCE; SMOKING; WAIST CIRCUMFERENCE;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; CONFIDENCE INTERVALS; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; INFLAMMATION; KAPLAN-MEIER ESTIMATE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SERUM ALBUMIN; SEX FACTORS; SOCIOECONOMIC FACTORS; SOUTHEASTERN UNITED STATES; WAIST CIRCUMFERENCE;

EID: 79960828074     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr085     Document Type: Article

References (24)

1. Idicula TT, Brogger J, Naess H, et al. Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: the 'Bergen stroke study'. BMC Neurol. 2009;9(1):18. (doi:10.1186/1471-2377-9-18).
2. Ray KK, Cannon CP, Cairns R, et al. Prognostic utility of apoB/ AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22. Arterioscler Thromb Vasc Biol. 2009;29(3):424-430.
3. Margolis KL, Manson JE, Greenland P, et al. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Women's Health Initiative Research Group. Arch Intern Med. 2005;165(5):500-508. (Pubitemid 40344380)
4. Danesh J, Collins R, Appleby P, et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998;279(18):1477-1482. (Pubitemid 28228207)
5. Grimm G, Haslacher H, Kampitsch T, et al. Sex differences in the association between albumin and all-cause and vascular mortality. Eur J Clin Invest. 2009;39(10):860-865.
6. Kaptoge S, Di Angelantonio E, Lowe G, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Emerging Risk Factors Collaboration. Lancet. 2010;375(9709): 132-140.
7. Cushman M. Leukocyte count in vascular risk prediction. Arch Intern Med. 2005;165(5):487-488. (Pubitemid 40344378)
8. Jenny NS, Yanez ND, Psaty BM, et al. Inflammation biomarkers and near-term death in older men. Am J Epidemiol. 2007;165(6):684-695. (Pubitemid 46348379)
9. Zakai NA, Katz R, Jenny NS, et al. Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study. J Thromb Haemost. 2007; 5(6):1128-1135. (Pubitemid 46902111)
10. Barzilay JI, Forsberg C, Heckbert SR, et al. The association of markers of inflammation with weight change in older adults: the Cardiovascular Health Study. Int J Obes (Lond). 2006; 30(9):1362-1367. (Pubitemid 44306518)
11. Lakoski SG, Cushman M, Criqui M, et al. Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J. 2006;152(3): 593-598. (Pubitemid 44233418)
12. Hsieh MM, Everhart JE, Byrd-Holt DD, et al. Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences. Ann Intern Med. 2007;146(7): 486-492. (Pubitemid 351650557)
13. Chen W, Srinivasan SR, Berenson GS. Influence of birth weight on white blood cell count in biracial (black-white) children, adolescents, and young adults: the Bogalusa Heart Study. Am J Epidemiol. 2009;169(2):214-218.
14. Rimm EB, Stampfer MJ, Giovannucci E, et al. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol. 1995;141(12):1117-1127.
15. Flegal KM, Graubard BI. Estimates of excess deaths associated with body mass index and other anthropometric variables. Am J Clin Nutr. 2009;89(4):1213-1219.
16. Howard VJ, Cushman M, Pulley L, et al. The Reasons for Geographic and Racial Differences in Stroke study: objectives and design. Neuroepidemiology. 2005;25(3):135-143. (Pubitemid 41207066)
17. Cushman M, McClure LA, Howard VJ, et al. Implications of increased C-reactive protein for cardiovascular risk stratification in black and white men and women in the US. Clin Chem. 2009;55(9):1627-1636.
18. Zakai NA, McClure LA, Prineas R, et al. Correlates of anemia in American blacks and whites: the REGARDS Renal Ancillary Study. Am J Epidemiol. 2009;169(3):355-364.
19. You Z, Cushman M, Jenny NS, et al. Tooth loss, systemic inflammation, and prevalent stroke among participants in the Reasons for Geographic and Racial Difference in Stroke (REGARDS) study. Atherosclerosis. 2009;203(2):615-619.
20. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157-172. (Pubitemid 351193639)
21. Liu S, Tinker L, Song Y, et al. A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. Arch Intern Med. 2007; 167(15):1676-1685. (Pubitemid 47280350)
22. Ridker PM, Danielson E, Fonseca FA, et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet. 2009;373(9670):1175-1182.
23. Joshi PH, Jacobson TA. Therapeutic options to further lower C-reactive protein for patients on statin treatment. Curr Atheroscler Rep. 2010;12(1):34-42.
24. Mora S, Ridker PM. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)-can C-reactive protein be used to target statin therapy in primary prevention? Am J Cardiol. 2006;97(2A):33A-41A. (Pubitemid 43139718)